Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Anemia

  Free Subscription


15.08.2022

5 Br J Haematol
17 Hemoglobin
1 N Engl J Med
2 PLoS One
1 Transfusion


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Br J Haematol

  1. GREEN NS, Van Doren L, Licursi M, Billings DD, et al
    Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City.
    Br J Haematol. 2022;198:680-683.
    PubMed        

  2. SHARMA A, Leonard A, West K, Gossett JM, et al
    Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.
    Br J Haematol. 2022;198:740-744.
    PubMed         Abstract available

  3. URSULE-DUFAIT C, Bengoufa D, Theodorou I, Villesuzanne C, et al
    Heavy chain/light chain assay is a useful biomarker for diagnosis and management of patients with cold agglutinin disease.
    Br J Haematol. 2022;198:e67-e70.
    PubMed        

  4. OGBENNA AA, Akinsete AM, Kalejaiye OO, Matthew OK, et al
    Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy.
    Br J Haematol. 2022;198:745-752.
    PubMed         Abstract available

  5. GELBENEGGER G, Jaeger U, Fillitz M, D'Sa S, et al
    Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.
    Br J Haematol. 2022;198:e59-e62.
    PubMed        


    Hemoglobin

  6. YADAV SS, Panchal P, Menon KC
    Prevalence and Management of beta-Thalassemia in India.
    Hemoglobin. 2022;46:27-32.
    PubMed         Abstract available

  7. ANURATHAPAN U, Pakakasama S, Songdej D, Pongphitcha P, et al
    Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia.
    Hemoglobin. 2022;46:2-6.
    PubMed         Abstract available

  8. CHEN P, Lin WX, Li SQ
    THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China.
    Hemoglobin. 2022;46:33-35.
    PubMed         Abstract available

  9. ALWI ZB, Syed-Hassan SR
    Thalassemia in Malaysia.
    Hemoglobin. 2022;46:45-52.
    PubMed         Abstract available

  10. BACH KQ, Nguyen HTT, Nguyen TH, Nguyen MB, et al
    Thalassemia in Viet Nam.
    Hemoglobin. 2022;46:62-65.
    PubMed         Abstract available

  11. PHENGSAVANH A, Sengchanh S, Souksakhone C, Souvanlasy B, et al
    Current Status of Thalassemia in Lao People's Democratic Republic.
    Hemoglobin. 2022;46:58-61.
    PubMed         Abstract available

  12. WAHIDIYAT PA, Sari TT, Rahmartani LD, Iskandar SD, et al
    Thalassemia in Indonesia.
    Hemoglobin. 2022;46:39-44.
    PubMed         Abstract available

  13. YUSON ED, Naranjo MLT
    Thalassemia in the Philippines.
    Hemoglobin. 2022;46:36-38.
    PubMed         Abstract available

  14. KHALIQ S
    Thalassemia in Pakistan.
    Hemoglobin. 2022;46:12-14.
    PubMed         Abstract available

  15. FUCHAROEN S, Ping C, Paiboonsukwong K
    Introduction to the Special Issue.
    Hemoglobin. 2022;46:1.
    PubMed        

  16. SOPHAL C
    Thalassemia Status in Cambodia.
    Hemoglobin. 2022;46:10-11.
    PubMed         Abstract available

  17. CHOWDHURY MA, Sultana R, Das D
    Thalassemia in Asia 2021 Overview of Thalassemia and Hemoglobinopathies in Bangladesh.
    Hemoglobin. 2022;46:7-9.
    PubMed         Abstract available

  18. PREMAWARDHENA AP, Madushanka HDP
    Thalassemia in Sri Lanka.
    Hemoglobin. 2022;46:71-73.
    PubMed         Abstract available

  19. COLAH RB, Seth T
    Thalassemia in India.
    Hemoglobin. 2022;46:20-26.
    PubMed         Abstract available

  20. KHAING AA, Myint PP, Paiboonsukwong K, Win N, et al
    Clinical Severity of beta-Thalassemia Pediatric Patients in Myanmar.
    Hemoglobin. 2022;46:66-70.
    PubMed         Abstract available

  21. CHONG SC, Metassan S, Yusof N, Idros R, et al
    Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam.
    Hemoglobin. 2022;46:15-19.
    PubMed         Abstract available

  22. PAIBOONSUKWONG K, Jopang Y, Winichagoon P, Fucharoen S, et al
    Thalassemia in Thailand.
    Hemoglobin. 2022;46:53-57.
    PubMed         Abstract available


    N Engl J Med

  23. ZHOU AE, Travassos MA
    Bringing Sickle-Cell Treatments to Children in Sub-Saharan Africa.
    N Engl J Med. 2022;387:488-491.
    PubMed        


    PLoS One

  24. OOI SW, Yeh ST, Chang YH, Li CY, et al
    Low mean HbA1c does not increase all-cause and cardiovascular mortality in patients with diabetes: Effect-modifications by anemia and chronic kidney disease stages.
    PLoS One. 2022;17:e0272137.
    PubMed         Abstract available

  25. AYNALEM M, Adem N, Wendesson F, Misganaw B, et al
    Hematological abnormalities before and after initiation of cancer treatment among breast cancer patients attending at the University of Gondar comprehensive specialized hospital cancer treatment center.
    PLoS One. 2022;17:e0271895.
    PubMed         Abstract available


    Transfusion

  26. COVINGTON ML, Cone-Sullivan JK, Andrzejewski C, Lu W, et al
    Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement.
    Transfusion. 2022;62:1662-1670.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: